Cited by 188Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature

Open access
Fernández-de-las-Peñas, César, Notarte, Kin Israel, Peligro, Princess Juneire, Velasco, Jacqueline Veronica, Ocampo, Miguel Joaquín, Henry, Brandon Michael, Arendt-Nielsen, Lars, Torres-Macho, Juan +1 more·2022·Viruses

Abstract

The association of SARS-CoV-2 variants with long-COVID symptoms is still scarce, but new data are appearing at a fast pace. This systematic review compares the prevalence of long-COVID symptoms according to relevant SARS-CoV-2 variants in COVID-19 survivors. The MEDLINE, CINAHL, PubMed, EMBASE and Web of Science databases, as well as the medRxiv and bioRxiv preprint servers, were searched up to 25 October 2022. Case-control and cohort studies analyzing the presence of post-COVID symptoms appearing after an acute SARS-CoV-2 infection by the Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529/BA.1) variants were included. Methodological quality was assessed using the Newcastle–Ottawa Scale. From 430 studies identified, 5 peer-reviewed studies and 1 preprint met the inclusion criteria. The sample included 355 patients infected with the historical variant, 512 infected with the Alpha variant, 41,563 infected with the Delta variant, and 57,616 infected with the Omicron variant. The methodological quality of all studies was high. The prevalence of long-COVID was higher in individuals infected with the historical variant (50%) compared to those infected with the Alpha, Delta or Omicron variants. It seems that the prevalence of long-COVID in individuals infected with the Omicron variant is the smallest, but current data are heterogeneous, and long-term data have, at this stage, an obviously shorter follow-up compared with the earlier variants. Fatigue is the most prevalent long-COVID symptom in all SARS-CoV-2 variants, but pain is likewise prevalent. The available data suggest that the infection with the Omicron variant results in fewer long-COVID symptoms compared to previous variants; however, the small number of studies and the lack of the control of cofounders, e.g., reinfections or vaccine status, in some studies limit the generality of the results. It appears that individuals infected with the historical variant are more likely to develop long-COVID symptomatology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/v14122629

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Since the observational periods of the included studies varied widely, we could not evaluate the impact of different variants of concern.

    “Fourth, since the observational periods of the included studies varied widely, we could not evaluate the impact of different variants of concern [41].”

    From Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis (2023) · cites this paper as [41]

    Methods §2.5 says differing follow-up periods and settings made a meta-analysis inappropriate, supporting the concern about varied observational periods. But the review did synthesize symptoms by variant; it does not say that this variation prevented evaluation of variant-related differences altogether. The citing authors’ statement about what they could not evaluate is their own limitation. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fernández-de-las-Peñas, C., Notarte, K. I., Peligro, P. J., Velasco, J. V., Ocampo, M. J., Henry, B. M., Arendt-Nielsen, L., Torres-Macho, J., & Plaza-Manzano, G.
Affiliations
  • Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, 28933 Madrid, Spain
  • Johns Hopkins University (US)
  • University of Santo Tomas (PH)
  • Cincinnati Children's Hospital Medical Center (US)
  • Department of Health Science and Technology, Faculty of Medicine, Center for Neuroplasticity and Pain (CNAP), Sensory Motor Interaction (SMI), Aalborg University, 9220 Aalborg, Denmark
  • Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain
  • Department of Physical Therapy, Universidad Complutense de Madrid, 28040 Madrid, Spain
Venue
Viruses
Publisher
MDPI AG
Published
2022-11-25
Volume
14
Issue
12
Pages
2629
ISSN
1999-4915 (ISSN-L)
OpenAlex
W4310215156
Cited by
184
References
43
Citations by year
2026: 18 · 2025: 40 · 2024: 66 · 2023: 58 · 2022: 2
FWCI
5.99
Type
journal article
Language
en
Open access
Locations
  • Viruses (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • VBN Forskningsportal (Aalborg Universitet) (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • the Fondo Europeo De Desarrollo Regional—Recursos REACT-UE del Programa Operativo de Madrid 2014–2020, en la línea de actuación de proyectos de I + D + i en materia de respuesta a COVID 19 (LONG-COVID-EXP-CM) (NNF21OC0067235)
  • the Novo Nordic Foundation (NNF21OC0067235)
Topics
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
long COVID, SARS-CoV-2 variants of concern, Omicron variant, Delta variant, Alpha variant, fatigue, pain, symptom prevalence, COVID-19 survivors
MeSH terms
COVID-19, SARS-CoV-2, Post-Acute COVID-19 Syndrome, Humans, Databases, Factual

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review